Department of Orthopedics, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Department of Orthopedics, Affiliated Hospital of Guangdong medical University, zhanjiang, 524000, China.
J Transl Med. 2024 Oct 15;22(1):941. doi: 10.1186/s12967-024-05752-0.
The prevalence of age-related degenerative joint diseases, particularly intervertebral disc degeneration and osteoarthritis, is increasing, thereby posing significant challenges for the elderly population. Mitochondrial dysfunction is a critical factor in the etiology and progression of these disorders. Therapeutic interventions that incorporate mitochondrial transplantation exhibit considerable promise by increasing mitochondrial numbers and improving their functionality. Existing evidence suggests that exogenous mitochondrial therapy improves clinical outcomes for patients with degenerative joint diseases. This review elucidates the mitochondrial abnormalities associated with degenerative joint diseases and examines the mechanisms of mitochondrial intercellular transfer and artificial mitochondrial transplantation. Furthermore, therapeutic strategies for mitochondrial transplantation in degenerative joint diseases are synthesized, and the concept of engineered mitochondrial transplantation is proposed.
与年龄相关的退行性关节疾病(尤其是椎间盘退变和骨关节炎)的患病率不断上升,这给老年人群带来了巨大挑战。线粒体功能障碍是这些疾病发生和进展的关键因素。通过增加线粒体数量和改善其功能,纳入线粒体移植的治疗干预措施具有很大的应用前景。现有证据表明,外源性线粒体治疗可改善退行性关节疾病患者的临床结局。本综述阐明了与退行性关节疾病相关的线粒体异常,并探讨了线粒体细胞间转移和人工线粒体移植的机制。此外,还综合了线粒体移植治疗退行性关节疾病的策略,并提出了工程化线粒体移植的概念。